Appears on
Articles2
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventative Medications
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventative Medications chavak11 Fri, 06/05/2026 - 09:51 Nurtec® ODT Rimegepant PHASE IV Mon, 11/07/2022 - 12:00 Tue, 07/08/2025 - 12:00 NCT05518123 C4951
0
Pfizer1mo agoFinal Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inf
Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inf chavak11 Wed, 06/10/2026 - 06:28 Abrysvo PF-06928316 PHASE III Tue, 03/12/2024 - 12:00 Wed, 06/11/2025 -
0
Pfizer1mo ago